Company Search:
Advanced Search
Sponsored Links
Veloxis Pharmaceuticals A/S Company Snapshot
Veloxis Pharmaceuticals A/S operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Veloxis Pharmaceuticals A/S with three other miscellaneous service companies in Europe: Formycon AG of Germany (2017 sales of 29.06 million Euro [US$33.03 million] ), Eurofins-Cerep SA of France (24.41 million Euro [US$27.74 million] ), and Brain Biotechnology Research and Information Network AG which is based in Germany (26.42 million Euro [US$30.02 million] of which 51% was BioIndustrial).

Sales Analysis. Sales increased substantially in 2017: During the year ended December of 2017, sales at Veloxis Pharmaceuticals A/S were 196.99 million Danish Kroner (US$30.01 million). This is an increase of 217.7% versus 2016, when the company's sales were 62.00 million Danish Kroner.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Veloxis Pharmaceuticals A/S
  Stock Performance Chart for Veloxis Pharmaceuticals A/S
  Stock Data: Recent Stock Performance:
  Current Price (12/14/2018): 1.92
(Figures in Danish Kroner)
1 Week 1.9%   13 Weeks 25.5%  
4 Weeks 83.2%   52 Weeks 112.2%  
Veloxis Pharmaceuticals A/S Key Data:
  Ticker: VELO Country: Denmark
  Exchanges: CPH Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 196,989,605
(Year Ending Jan 2018).
Employees: 51
  Currency: Danish Kroner Market Cap: 3,288,649,980
  Fiscal Yr Ends: December Shares Outstanding: 1,712,838,531
  Share Type: Stammaktie Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.